Biocon logo

Biocon

Asia, Karnataka, India, Bangalore

Description

Biocon is a healthcare and technology, company focused on biotechnology.

Investor Profile

Biocon has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 3 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series D rounds (top funding stages).
  • Majority of deals are located in United States, India.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Seed (50%)
  • Series D (50%)

Country Focus

  • United States (50%)
  • India (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical Device
  • Nanotechnology
  • Banking
  • Finance
  • Financial Services
  • Fintech
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Biocon frequently co-invest with?

Creation Investments Capital Management, LLC
North America, Illinois, United States, Chicago
Co-Investments: 1
GAWA Capital
Europe, Madrid, Spain, Madrid
Co-Investments: 1
Aspect Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
Oikocredit International
Europe, Utrecht, The Netherlands, Amersfoort
Co-Investments: 1

What are some of recent deals done by Biocon?

Fusion Microfinance

New Delhi, Delhi, India

Fusion Microfinance is a New Delhi-based micro-lending startup aiming to provide underprivileged women with economic opportunities.

BankingFinanceFinancial ServicesFinTech
Series DAug 11, 2016
Amount Raised: $24,000,000
Glympse Bio

Cambridge, Massachusetts, United States

Glympse Bio is a biotechnology company that transforms disease detection and predict treatment response.

BiotechnologyHealth CareLife ScienceMedical DeviceNanotechnology
SeedDec 1, 2015
Amount Raised: $6,600,000